Skip to main content
OpenTrials
Completed

NCT Number: NCT00347321

Early Percutaneous Tracheostomy for Cardiac Surgery (ETOC)

This is a phase III clinical trial comparing early tracheostomy (day 4) versus prolonged endotracheal intubation in ICU patients needing prolonged ventilatory support after cardiovascular surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Institut de Cardiologie - Chu Pitie Salpetriere Ap-Hp

Paris, 75013, France

About this study

Background: Prolonged mechanical ventilation (MV> 7 days) is required in less than 10% of patients after cardiovascular surgery but it is associated with high morbidity and mortality.

Several studies conducted in critically ill patients suggested that early percutaneous tracheotomy compared with delayed tracheotomy decreases the length of ventilator dependence and improves outcome. To date, no randomized trial has tested these possible benefits in critically ill patients after cardiac surgery.

Study objectives: A randomized trial has been designed to determine whether early tracheostomy (day 4 after cardiac surgery) in patients still on MV would reduce the number of days under MV, measured by the evaluation of ventilator-free days (VFDs). Secondary objectives are the reduction of mortality, reduction of ICU and hospital length of stay. Evaluation of organ failure evolution, infectious complications, sedation needs, patient comfort and outcome at 3 months will be also considered.

Study hypothesis: The trial will be consider positive if early tracheotomy increases the number VFDs of at least 7 days (mean) evaluated on day 60 after randomisation.

Methods :

Trial : randomized, open, controlled, monocentric Inclusion criteria: see columns below Exclusion criteria: see columns below Randomization: will use a computerised system on day 4 after cardiac surgery Procedures: see columns below Recorded data: demographic characteristics, pre, per and postoperative parameters.

From randomization until ICU discharge (or day 60), a daily chart will be completed.

Judgment criteria: see columns below Sample size and statistical analysis: using Wilcoxon bilateral test with an alpha risk of 5% and a power of 80%, we calculated that 108 patients in each arm would be needed.

Statistical analyses will use standard tests to compare population of the two arms.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Are 18 years of age or older
  • Have undergone cardiovascular surgery
  • Are still on invasive mechanical ventilation on day 4 after surgery
  • Have failed the screening test or the spontaneous breathing trial
  • Have signed the informed consent (patient or legal representative)

Exclusion criteria

  • Age less than18
  • Pregnant woman
  • Intubation more than 48 hours before cardiovascular surgery
  • More than 5 days on mechanical ventilation after cardiac surgery
  • Artificial heart implantation
  • Concomitant neck surgery (carotid)
  • Previously tracheostomized
  • Major hemorrhagic risk
  • Persistence of platelet count less than 50.000/mm3 after platelet transfusion
  • Prothrombin time less than 30% despite coagulation factors administration
  • Clinical evidence of ongoing infection at the proposed tracheotomy site
  • Anatomical deformity of the neck making risky a tracheostomy
  • Probability of dying the day of randomization defined by SAPSII more than 80
  • Irreversible neurological lesions
  • Decision of care limitation
  • Prior inclusion in a trial with morbidity-mortality as main judgement criteria
  • Previous enrollment in this trial
  • Consent refusal

Treatment and study plan

Dilatational Percutaneous tracheostomy

Procedure

Dilatational Percutaneous tracheostomy

Primary outcomes

  1. Number of ventilator-free days defined as the number of days between successful weaning from MV and day 60 after study enrolment.

    Time frame: between successful weaning from MV and day 60 after study enrolment.

  2. VFDs = 0 if the patient dies before 60days.

    Time frame: before 60 days

  3. VFDs= (60- X) : if the patient is successfully weaned from MV within 60 days, where X is the number of days spent receiving MV

    Time frame: during 60 days

  4. VFDs = 0: if the patient requires MV for 60 days or more

    Time frame: during 60 days and after

  5. The trial will be considered positive if early tracheostomy increases the number VFDs of at least 7 days (mean)

    Time frame: at 7 days

Secondary outcomes

  1. Other outcomes will be compared between the two arms:

    Time frame: during the trial

  2. Mortality rate (day 60, in-ICU, in-hospital)

    Time frame: during the 60 days

  3. ICU length of stay

    Time frame: during the trial

  4. Hospital length of stay

    Time frame: during the trial

  5. Duration of MV in survivors

    Time frame: during the trial

  6. Organ failure evolution

    Time frame: during the trial

  7. Infectious complications

    Time frame: during the trial

  8. Early laryngeal and tracheal complications

    Time frame: during the trial

  9. Sedation needs

    Time frame: during the trial

  10. Patient comfort

    Time frame: during the trial

  11. Outcome on day 90

    Time frame: to 90 days

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

Registry information

Official study title

Evaluation of Early Percutaneous Tracheostomy in Patients Undergoing Cardiovascular Surgery and Requiring Prolonged Mechanical Ventilation

Acronym: ETOC

Important dates

Study start
2006
Primary completion
2009
Study completion
2009
First posted
Jul 4, 2006
Registry last updated
Dec 3, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.